These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25394537)

  • 1. Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation.
    Vos R; Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Neyrinck A; Van Raemdonck DE; Yserbyt J; Dupont LJ; Verbeken EK; Moelants E; Mortier A; Proost P; Schols D; Cox B; Verleden GM; Vanaudenaerde BM
    Am J Transplant; 2014 Dec; 14(12):2736-48. PubMed ID: 25394537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.
    Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA
    Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance.
    Vandermeulen E; Verleden SE; Ruttens D; Moelants E; Mortier A; Somers J; Bellon H; Piloni D; Dupont LJ; Van Raemdonck DE; Proost P; Schols D; Vos R; Verleden GM; Vanaudenaerde BM
    Transpl Immunol; 2015 Sep; 33(1):37-44. PubMed ID: 26168736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.
    Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
    Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
    Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
    Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
    [No Abstract]   [Full Text] [Related]  

  • 7. CLAD: does the Emperor have new clothes?
    Glanville AR
    Am J Transplant; 2014 Dec; 14(12):2681-2. PubMed ID: 25394597
    [No Abstract]   [Full Text] [Related]  

  • 8. The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.
    Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Saggar R; Huynh RH; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2018 Jan; 18(1):136-144. PubMed ID: 28637080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.
    Spence CD; Vanaudenaerde B; Einarsson GG; Mcdonough J; Lee AJ; Johnston E; Verleden GM; Elborn JS; Dupont LJ; Van Herck A; Gilpin DF; Vos R; Tunney MM; Verleden SE
    J Heart Lung Transplant; 2020 Feb; 39(2):176-183. PubMed ID: 31812487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.
    Ruttens D; Verleden SE; Vandermeulen E; Bellon H; Vanaudenaerde BM; Somers J; Schoonis A; Schaevers V; Van Raemdonck DE; Neyrinck A; Dupont LJ; Yserbyt J; Verleden GM; Vos R
    Am J Transplant; 2016 Jan; 16(1):254-61. PubMed ID: 26372728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
    Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
    Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thin-section computed tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction.
    de Jong PA; Vos R; Verleden GM; Vanaudenaerde BM; Verschakelen JA
    Eur Radiol; 2011 Dec; 21(12):2466-74. PubMed ID: 21792614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation.
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Dupont LJ; Van Raemdonck DE; Verleden GM
    Transplant Proc; 2009 Oct; 41(8):3409-13. PubMed ID: 19857759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage.
    Ross DJ; Moudgil A; Bagga A; Toyoda M; Marchevsky AM; Kass RM; Jordan SC
    J Heart Lung Transplant; 1999 Jul; 18(7):627-36. PubMed ID: 10452338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction.
    Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A;
    Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis.
    Vos R; Vanaudenaerde BM; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Van Raemdonck DE; Dupont LJ; Nawrot TS; Verbeken EK; Verleden GM
    J Heart Lung Transplant; 2010 Nov; 29(11):1259-69. PubMed ID: 20673640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.
    Van Herck A; Frick AE; Schaevers V; Vranckx A; Verbeken EK; Vanaudenaerde BM; Sacreas A; Heigl T; Neyrinck AP; Van Raemdonck D; Dupont LJ; Yserbyt J; Verleden SE; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Mar; 38(3):252-259. PubMed ID: 30686699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene signatures common to allograft rejection are associated with lymphocytic bronchitis.
    Greenland JR; Wang P; Brotman JJ; Ahuja R; Chong TA; Kleinhenz ME; Leard LE; Golden JA; Hays SR; Kukreja J; Singer JP; Rajalingam R; Jones K; Laszik ZG; Trivedi NN; Greenland NY; Blanc PD
    Clin Transplant; 2019 May; 33(5):e13515. PubMed ID: 30849195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ; Marchevsky A; Kramer M; Kass RM
    J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "White-Out" After Lung Transplantation: A Multicenter Cohort Description of Late Acute Graft Failure.
    Verleden SE; Gottlieb J; Dubbeldam A; Verleden GM; Suhling H; Welte T; Vos R; Greer M
    Am J Transplant; 2017 Jul; 17(7):1905-1911. PubMed ID: 28296181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.